{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:11:06Z","timestamp":1789603866095,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.phrs.2013.09.003","type":"journal-article","created":{"date-parts":[[2013,9,18]],"date-time":"2013-09-18T13:35:55Z","timestamp":1379511355000},"page":"39-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["The novel antiepileptic drug imepitoin compares favourably to other GABA-mimetic drugs in a seizure threshold model in mice and dogs"],"prefix":"10.1016","volume":"77","author":[{"given":"Wolfgang","family":"L\u00f6scher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Twele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidrun","family":"Potschka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"T\u00f6llner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2013.09.003_bib0005","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.injury.2010.03.032","article-title":"Animal models of traumatic brain injury: is there an optimal model to reproduce human brain injury in the laboratory?","volume":"41","author":"Morganti-Kossmann","year":"2010","journal-title":"Injury"},{"key":"10.1016\/j.phrs.2013.09.003_bib0010","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00335-011-9348-0","article-title":"The function of dog models in developing gene therapy strategies for human health","volume":"22","author":"Nowend","year":"2011","journal-title":"Mamm Genome"},{"key":"10.1016\/j.phrs.2013.09.003_bib0015","doi-asserted-by":"crossref","first-page":"497841","DOI":"10.1155\/2011\/497841","article-title":"Animal models of cardiovascular diseases","volume":"2011","author":"Zaragoza","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.phrs.2013.09.003_bib0020","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2174\/156720512800107546","article-title":"Dogs with cognitive dysfunction syndrome: a natural model of Alzheimer's disease","volume":"9","author":"Bosch","year":"2012","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.phrs.2013.09.003_bib0025","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.bbadis.2011.09.020","article-title":"Antioxidants in the canine model of human aging","volume":"1822","author":"Dowling","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.phrs.2013.09.003_bib0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.eplepsyres.2011.05.011","article-title":"A novel implanted device to wirelessly record and analyze continuous intracranial canine EEG","volume":"96","author":"Davis","year":"2011","journal-title":"Epilepsy Res"},{"issue":"Suppl. 8","key":"10.1016\/j.phrs.2013.09.003_bib0035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1528-1167.2011.03231.x","article-title":"Canine status epilepticus: a translational platform for human therapeutic trials","volume":"52","author":"Leppik","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2013.09.003_bib0040","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/epi.12138","article-title":"Canine epilepsy as a translational model","volume":"54","author":"Potschka","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2013.09.003_bib0045","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/epi.12071","article-title":"Epilepsy after head injury in dogs: a natural model of posttraumatic epilepsy","volume":"54","author":"Steinmetz","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2013.09.003_bib0050","first-page":"276","article-title":"Evaluation of anticonvulsant drugs in genetic animal models of epilepsy","volume":"43","author":"L\u00f6scher","year":"1984","journal-title":"Fed Proc"},{"key":"10.1016\/j.phrs.2013.09.003_bib0055","first-page":"82","article-title":"Evaluation of epileptic dogs as an animal model of human epilepsy","volume":"35","author":"L\u00f6scher","year":"1985","journal-title":"Arzneim Forsch (Drug Res)"},{"key":"10.1016\/j.phrs.2013.09.003_bib0060","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1528-1157.1970.tb03892.x","article-title":"Comparative clinical and electroencephalographic studies of canine epilepsy","volume":"11","author":"Holliday","year":"1970","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2013.09.003_bib0065","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0195-5616(96)50105-1","article-title":"Seizures in dogs","volume":"26","author":"Podell","year":"1996","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10.1016\/j.phrs.2013.09.003_bib0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1939-1676.1999.tb02159.x","article-title":"Epilepsy and seizure classification in 63 dogs: a reappraisal of veterinary epilepsy terminology","volume":"13","author":"Berendt","year":"1999","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.phrs.2013.09.003_bib0075","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1600-0404.1999.tb00676.x","article-title":"Electroencephalography in dogs with epilepsy: similarities between human and canine findings","volume":"99","author":"Berendt","year":"1999","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.phrs.2013.09.003_bib0080","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/vr.101133","article-title":"Prevalence and risk factors for canine epilepsy of unknown origin in the UK","volume":"172","author":"Kearsley-Fleet","year":"2013","journal-title":"Vet Rec"},{"key":"10.1016\/j.phrs.2013.09.003_bib0085","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1939-1676.2009.0407.x","article-title":"Placebo effect in canine epilepsy trials","volume":"24","author":"Munana","year":"2010","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.phrs.2013.09.003_bib0090","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1939-1676.2011.00866.x","article-title":"Evaluation of levetiracetam as adjunctive treatment for refractory canine epilepsy: a randomized, placebo-controlled, crossover trial","volume":"26","author":"Munana","year":"2012","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.phrs.2013.09.003_bib0095","series-title":"Appropriate dose selection \u2013 how to optimize clinical drug development","author":"Venitz","year":"2007"},{"key":"10.1016\/j.phrs.2013.09.003_bib0100","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1365-2885.2007.00906.x","article-title":"Development and validation of the maximal electro-shock seizure model in dogs","volume":"30","author":"Territo","year":"2007","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1016\/j.phrs.2013.09.003_bib0105","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1152\/jappl.1967.22.2.321","article-title":"Responses of dogs to hyperoxic-, pentylenetetrazol-, and electroshock-induced convulsions","volume":"22","author":"Gutsche","year":"1967","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.phrs.2013.09.003_bib0110","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1528-1157.1978.tb05024.x","article-title":"Anticonvulsant properties of ropizine in epileptic and nonepileptic beagle dogs","volume":"19","author":"Edmonds","year":"1978","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2013.09.003_bib0115","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1365-2885.2008.00995.x","article-title":"Nonlinear mixed effects pharmacokinetic\/pharmacodynamic analysis of the anticonvulsant ameltolide (LY201116) in a canine seizure model","volume":"31","author":"Territo","year":"2008","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1016\/j.phrs.2013.09.003_bib0120","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0006-8993(02)03430-3","article-title":"Complex partial status epilepticus induced by a microinjection of kainic acid into unilateral amygdala in dogs and its brain damage","volume":"955","author":"Hasegawa","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.phrs.2013.09.003_bib0125","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0013-4694(62)90035-4","article-title":"Intravenous, cortical and intraventricular dose\u2013effect relationship of pentylenetetrazol, picrotoxin and deslanoside in dogs","volume":"14","author":"Bircher","year":"1962","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.phrs.2013.09.003_bib0130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1152\/ajplegacy.1963.205.2.225","article-title":"Pentylenetetrazol (metrazol) shock in normal and adrenalectomized dogs","volume":"205","author":"Swingle","year":"1963","journal-title":"Am J Physiol"},{"key":"10.1016\/j.phrs.2013.09.003_bib0135","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1528-1157.1992.tb01751.x","article-title":"Inhibition of experimental seizures in canines by repetitive vagal stimulation","volume":"33","author":"Zabara","year":"1992","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2013.09.003_bib0140","first-page":"1933","article-title":"In vivo detection of postictal perturbations of cerebral metabolism by use of proton MR spectroscopy: preliminary results in a canine model of prolonged generalized seizures","volume":"22","author":"Neppl","year":"2001","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.phrs.2013.09.003_bib0145","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.0013-9580.2004.21204.x","article-title":"Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures","volume":"45","author":"L\u00f6scher","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2013.09.003_bib0150","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1471-4159.1982.tb10886.x","article-title":"Relationship between GABA concentrations in cerebrospinal fluid and seizure excitability","volume":"38","author":"L\u00f6scher","year":"1982","journal-title":"J Neurochem"},{"key":"10.1016\/j.phrs.2013.09.003_bib0155","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0197-0186(83)90069-4","article-title":"Alterations in CSF GABA levels and seizure susceptibility developing during repeated administration of pentetrazole in dogs. Effects of y-acetylenic GABA, valproic acid and phenobarbital","volume":"5","author":"L\u00f6scher","year":"1983","journal-title":"Neurochem Int"},{"key":"10.1016\/j.phrs.2013.09.003_bib0160","first-page":"541","article-title":"Pharmacokinetics, anticonvulsant efficacy and adverse effects of the \u03b2-carboline abecarnil, a novel ligand for benzodiazepine receptors, after acute and chronic administration in dogs","volume":"255","author":"L\u00f6scher","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.phrs.2013.09.003_bib0165","series-title":"Anxiolytic \u03b2-carbolines: from molecular biology to the clinic","first-page":"96","article-title":"Abecarnil shows reduced tolerance development and dependence potential in comparison to diazepam: animal studies","author":"L\u00f6scher","year":"1993"},{"key":"10.1016\/j.phrs.2013.09.003_bib0170","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0920-1211(91)90053-I","article-title":"Trans-2-en-valproate: reevaluation of its anticonvulsant efficacy in standardized seizure models in mice, rats and dogs","volume":"9","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.phrs.2013.09.003_bib0175","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.eplepsyres.2012.10.001","article-title":"Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI)","volume":"103","author":"Bialer","year":"2013","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.phrs.2013.09.003_bib0180","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3940(98)00186-4","article-title":"The antiepileptic drug AWD 131\u2013138 stimulates different recombinant isoforms of the rat GABA(A) receptor through the benzodiazepine binding site","volume":"245","author":"Sigel","year":"1998","journal-title":"Neurosci Lett"},{"issue":"Suppl. 8","key":"10.1016\/j.phrs.2013.09.003_bib0185","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/epi.12026","article-title":"How phenobarbital revolutionized epilepsy therapy: the story of phenobarbital therapy in epilepsy in the last 100 years","volume":"53","author":"Yasiry","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2013.09.003_bib0190","series-title":"Epilepsy and GABA receptor agonists: basic and therapeutic research","first-page":"109","article-title":"GABAmimetics in animal models of seizure states","author":"L\u00f6scher","year":"1985"},{"key":"10.1016\/j.phrs.2013.09.003_bib0195","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0920-1211(91)90062-K","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs: III. Pentylenetetrazol seizure models","volume":"8","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.phrs.2013.09.003_bib0200","series-title":"Anxiolytic \u03b2-carbolines","first-page":"79","article-title":"Abecarnil: a novel anxiolytic with mixed full agonist\/partial agonist properties in animal models of anxiety and sedation","author":"Stephens","year":"1993"},{"issue":"Suppl. 8","key":"10.1016\/j.phrs.2013.09.003_bib0205","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/epi.12025","article-title":"How theories evolved concerning the mechanism of action of barbiturates","volume":"53","author":"L\u00f6scher","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2013.09.003_bib0210","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1528-1167.2007.01093.x","article-title":"The pharmacokinetics of antiepileptic drugs in rats: consequences for maintaining effective drug levels during prolonged drug administration in rat models of epilepsy","volume":"48","author":"L\u00f6scher","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2013.09.003_bib0215","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3940(02)00423-8","article-title":"P-glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood\u2013brain barrier: evidence from microdialysis experiments in rats","volume":"327","author":"Potschka","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.phrs.2013.09.003_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0920-1211(91)90041-D","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs: IV. Protective indices","volume":"9","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.phrs.2013.09.003_bib0225","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0920-1211(90)90013-L","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs: I. The influence of administration vehicles","volume":"7","author":"L\u00f6scher","year":"1990","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.phrs.2013.09.003_bib0230","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1358\/dof.1998.023.03.450427","article-title":"AWD-131-138","volume":"23","author":"Rostock","year":"1998","journal-title":"Drugs Future"},{"key":"10.1016\/j.phrs.2013.09.003_bib0235","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.tips.2012.08.003","article-title":"Anxioselective anxiolytics: on a quest for the Holy Grail","volume":"33","author":"Skolnick","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.phrs.2013.09.003_bib0240","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0165-6147(96)10015-8","article-title":"Benzodiazepines on trial: a research strategy for their rehabilitation","volume":"17","author":"Costa","year":"1996","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.phrs.2013.09.003_bib0245","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0165-0173(98)00052-6","article-title":"An update on GABAA receptors","volume":"29","author":"Mehta","year":"1999","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.phrs.2013.09.003_bib0250","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.neuropharm.2010.10.020","article-title":"The rise of a new GABA pharmacology","volume":"60","author":"M\u00f6hler","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2013.09.003_bib0255","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0014-2999(03)01533-4","article-title":"Evaluation of the novel antiepileptic drug, AWD 131\u2013138, for benzodiazepine-like discriminative stimulus and reinforcing effects in squirrel monkeys","volume":"465","author":"Yasar","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.phrs.2013.09.003_bib0260","first-page":"558","article-title":"Anticonvulsant drugs used in the treatment of epilepsy","volume":"1","author":"Frey","year":"1989","journal-title":"Probl Vet Med"},{"key":"10.1016\/j.phrs.2013.09.003_bib0265","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2885.1985.tb00951.x","article-title":"Pharmacokinetics of anti-epileptic drugs in the dog: a review","volume":"8","author":"Frey","year":"1985","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1016\/j.phrs.2013.09.003_bib0270","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1212\/WNL.33.3.283","article-title":"Primidone, phenobarbital and PEMA: I. Seizure protection, neurotoxicity and therapeutic index of individual compounds in mice","volume":"33","author":"Bourgeois","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2013.09.003_bib0275","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2460\/javma.240.9.1073","article-title":"Comparison of phenobarbital with bromide as a first-choice antiepileptic drug for treatment of epilepsy in dogs","volume":"240","author":"Boothe","year":"2012","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.phrs.2013.09.003_bib0280","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2885.1985.tb00934.x","article-title":"Therapeutic efficacy of phenobarbital and primidone in canine epilepsy: a comparison","volume":"8","author":"Schwartz-Porsche","year":"1985","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1016\/j.phrs.2013.09.003_bib0285","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs \u2013 best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2013.09.003_bib0290","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0014-2999(91)90271-Q","article-title":"Tolerance to anticonvulsant effects of the partial benzodiazepine receptor agonist abecarnil in kindled rats involves learning","volume":"202","author":"L\u00f6scher","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.phrs.2013.09.003_bib0295","first-page":"693","article-title":"Anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. Comparison of diazepam, bretazenil and abecarnil","volume":"275","author":"Rundfeldt","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.phrs.2013.09.003_bib0300","first-page":"561","article-title":"Long-term studies on anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice: I. Comparison of diazepam, clonazepam, clobazam, and abecarnil","volume":"279","author":"L\u00f6scher","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.phrs.2013.09.003_bib0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2009.03.025","article-title":"Preclinical assessment of proconvulsant drug activity and its relevance for predicting adverse events in humans","volume":"610","author":"L\u00f6scher","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.phrs.2013.09.003_bib0310","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0920-1211(88)90054-X","article-title":"Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations","volume":"2","author":"L\u00f6scher","year":"1988","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.phrs.2013.09.003_bib0315","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tvjl.2005.04.003","article-title":"Anticonvulsant activity and tolerance of ELB138 in dogs with epilepsy: a clinical pilot study","volume":"172","author":"Rieck","year":"2006","journal-title":"Vet J"},{"key":"10.1016\/j.phrs.2013.09.003_bib0320","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.yebeh.2011.03.018","article-title":"Behavioral changes in dogs associated with the development of idiopathic epilepsy","volume":"21","author":"Shihab","year":"2011","journal-title":"Epilepsy Behav"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661813001540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661813001540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T01:51:05Z","timestamp":1563933065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661813001540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":64,"alternative-id":["S1043661813001540"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2013.09.003","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The novel antiepileptic drug imepitoin compares favourably to other GABA-mimetic drugs in a seizure threshold model in mice and dogs","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2013.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}